Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Argus Health
Federal Trade Commission
Healthtrust
Cantor Fitzgerald
AstraZeneca

Generated: March 21, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LORCASERIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Lorcaserin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00395135 BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management Completed Arena Pharmaceuticals Phase 3 The purpose of this study is to assess the weight loss effect of lorcaserin at the end of the first year of treatment (Week 52) and to assess the ability of lorcaserin to maintain weight loss at the end of the second year of treatment (Week 104)
NCT00603291 BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus Completed Arena Pharmaceuticals Phase 3 The purpose of this study is to assess the weight loss effect of lorcaserin during and at the end of 1 year of treatment in overweight and obese patients with Type II diabetes mellitus treated with metformin, sulfonylurea (SFU), or either agent in combination with other oral hypoglycemic agents.
NCT00603902 BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management Completed Arena Pharmaceuticals Phase 3 The purpose of this study is to assess the weight loss effect of lorcaserin during and at the end of 1 year of treatment in overweight and obese patients.
NCT00828438 Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment Completed Arena Pharmaceuticals Phase 1 The purpose of this study is to evaluate the PK properties of lorcaserin in subjects with end stage renal disease (ESRD) who require dialysis and will be studied under dialysis and non-dialysis conditions.
NCT00828581 Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects Completed Arena Pharmaceuticals Phase 1 The purpose of this study is to evaluate the PK properties of lorcaserin in obese or overweight elderly subjects.
NCT00828659 Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users Completed Arena Pharmaceuticals Phase 1 The purpose of this study is to evaluate the abuse potential of lorcaserin in healthy recreational polydrug users.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Lorcaserin Hydrochloride

Condition Name

Condition Name for Lorcaserin Hydrochloride
Intervention Trials
Obesity 13
Overweight 3
Opioid-Related Disorders 2
Weight Gain 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lorcaserin Hydrochloride
Intervention Trials
Overweight 11
Disease 8
Obesity 6
Weight Loss 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lorcaserin Hydrochloride

Trials by Country

Trials by Country for Lorcaserin Hydrochloride
Location Trials
United States 109
Canada 6
New Zealand 6
Australia 6
Mexico 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lorcaserin Hydrochloride
Location Trials
New York 9
California 9
North Carolina 6
Florida 6
Virginia 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lorcaserin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Lorcaserin Hydrochloride
Clinical Trial Phase Trials
Phase 4 6
Phase 3 5
Phase 2/Phase 3 2
[disabled in preview] 28
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lorcaserin Hydrochloride
Clinical Trial Phase Trials
Completed 17
Recruiting 11
Not yet recruiting 9
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lorcaserin Hydrochloride

Sponsor Name

Sponsor Name for Lorcaserin Hydrochloride
Sponsor Trials
Arena Pharmaceuticals 11
National Institute on Drug Abuse (NIDA) 9
Eisai Inc. 5
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lorcaserin Hydrochloride
Sponsor Trials
Other 29
Industry 19
NIH 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Colorcon
Queensland Health
Baxter
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.